Nessan Bermingham serves as Executive at Intellia Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Nessan Bermingham has executed 12 insider transactions totaling $7.0M, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 3, 2023 involved receiving (via award) 35,114 shares valued at $0.
Nessan Bermingham currently holds 35,114 shares of Intellia Therapeutics, Inc. (NTLA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Nessan Bermingham has been a net seller of NTLA stock. They have purchased $0 and sold $7.0M worth of shares.
Nessan Bermingham's most recent insider trade was on Nov 3, 2023, when they sold 35,114 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $7.12 |
| Discretionary |
| Mar 8, 2023 | FSTX | $694.5K | Tender | 97,547 | $7.12 | Discretionary |
| Feb 1, 2021 | FSTX | $0 | Award | 87,000 | $N/A | Discretionary |
| Nov 20, 2020 | FSTX | $0 | Award | 16,875 | $N/A | Discretionary |
| Dec 8, 2017 | NTLA | $2.0M | Sale | 94,143 | $20.82 | Discretionary |
| Dec 7, 2017 | NTLA | $591.6K | Sale | 27,566 | $21.46 | Discretionary |
| Dec 7, 2017 | NTLA | $2.2M | Sale | 103,574 | $21.05 | Discretionary |
| Dec 6, 2017 | NTLA | $259.8K | Sale | 12,467 | $20.84 | Discretionary |
| Dec 6, 2017 | NTLA | $2.0M | Sale | 99,033 | $20.28 | Discretionary |
| Jun 1, 2017 | NTLA | $100.4K | Award | 8,400 | $11.95 | Discretionary |
| May 11, 2016 | NTLA | $0 | Conversion | 437,019 | $N/A | Discretionary |